Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin ∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/

1990, The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation, NEJM, 323, 1505, 10.1056/NEJM199011293232201 Clagett, 1995, Prevention of venous thromboembolism, Chest, 108, 312s, 10.1378/chest.108.4_Supplement.312S Connolly, 1991, Canadian atrial fibrillation anticoagulation (CAFA) study, J Am Coll Cardiol, 18, 349, 10.1016/0735-1097(91)90585-W Ezekowitz, 1992, Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation, NEJM, 327, 1406, 10.1056/NEJM199211123272002 Petersen, 1989, Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation, Lancet, 1, 175, 10.1016/S0140-6736(89)91200-2 Saour, 1990, Trial of different intensities of anticoagulant therapy in patients with substitute heart valves, NEJM, 322, 427, 10.1056/NEJM199002153220703 Smith, 1990, The effect of warfarin on mortality and reinfarction after myocardial infarction, NEJM, 323, 147, 10.1056/NEJM199007193230302 1991, Stroke prevention in atrial fibrillation study. Final results, Circulation, 84, 527, 10.1161/01.CIR.84.2.527 Antani, 1996, Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation, J Gen Intern Med, 11, 713, 10.1007/BF02598984 Beyth, 1996, Why isn’t warfarin prescribed to patients with nonrheumatic atrial fibrillation? A study of physicians’ opinions and their relationship to clinical characteristics and the physicians’ prescribing practices, J Gen Intern Med, 11, 721, 10.1007/BF02598985 Chang, 1990, Physician variation in anticoagulating patients with atrial fibrillation, Arch Intern Med, 150, 81, 10.1001/archinte.1990.00390130089012 Flegel, 1991, Factors relevant to preventing embolic stroke in patients with non-rheumatic atrial fibrillation, J Clin Epidemiol, 44, 551, 10.1016/0895-4356(91)90219-Y Gottlieb, 1994, Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?, Arch Intern Med, 154, 1945, 10.1001/archinte.1994.00420170093009 Kutner, 1991, Physicians’ attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation, Arch Intern Med, 151, 1950, 10.1001/archinte.1991.00400100038006 McCrory, 1995, Physician attitudes about anticoagulation for nonvalvular atrial fibrillation, Arch Intern Med, 155, 277, 10.1001/archinte.1995.00430030071008 Baker, 1962, Anticoagulant therapy in cerebral infarction, Neurology, 12, 832, 10.1212/WNL.12.12.823 Enger, 1965, Long-term anticoagulant therapy in patients with cerebral infarction, Act Med Scand, 178, 7 Fihn, 1993, Risk factors for complications of chronic anticoagulation. A multicenter study, Ann Intern Med, 118, 511, 10.7326/0003-4819-118-7-199304010-00005 Gitter, 1995, Bleeding and thromboembolism while receiving anticoagulation therapy, Mayo Clin Proc, 70, 725, 10.4065/70.8.725 Landefeld, 1987, Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy, Am J Med, 82, 703, 10.1016/0002-9343(87)90004-0 Landefeld, 1989, Major bleeding in outpatients treated with warfarin, Am J Med, 87, 144, 10.1016/S0002-9343(89)80689-8 Launbjerg, 1991, Bleeding complications to oral anticoagulant therapy, J Intern Med, 229, 351, 10.1111/j.1365-2796.1991.tb00358.x Lundstrom, 1989, Hemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis, J Intern Med, 225, 137, 10.1111/j.1365-2796.1989.tb00053.x McMahan, 1996, Risk of major hemorrhage for outpatients on warfarin therapy, J Gen Intern Med, 11, 80 Pollard, 1962, Problems associated with long-term anticoagulant therapy, Circulation, 25, 311, 10.1161/01.CIR.25.2.311 Landefeld, 1990, A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy, Am J Med, 89, 569, 10.1016/0002-9343(90)90174-C Landefeld, 1989, The bleeding severity index, J Clin Epidemiol, 42, 711, 10.1016/0895-4356(89)90066-8 Harrell, 1982, Evaluating the yield of medical tests, JAMA, 247, 2543, 10.1001/jama.1982.03320430047030 Harrell, 1996, Tutorial in biostatistics. Multivariable prognostic models, Statistics in Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 Braitman, 1996, Predicting clinical states in individual patients, Ann Intern Med, 125, 406, 10.7326/0003-4819-125-5-199609010-00008 SAS Institute Inc. SAS/STAT software: the PHREG procedure Version 6. SAS technical report P-217, 1-59; 1991. Cary, NC. (GENERC) Ref Type: Report Gurwitz, 1988, Age-related risks of long-term oral anticoagulant therapy, Arch Intern Med, 148, 1733, 10.1001/archinte.1988.00380080037012 Fihn, 1996, The risk and severity of bleeding complications in elderly patients treated with warfarin, Ann Intern Med, 124, 970, 10.7326/0003-4819-124-11-199606010-00004 1994, Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation, Lancet, 343, 687 Coon, 1974, Hemorrhagic complications of anticoagulant therapy, Arch Intern Med, 133, 386, 10.1001/archinte.1974.00320150060006 Palareti, 1996, Bleeding complications of oral anticoagulant treatment, Lancet, 348, 423, 10.1016/S0140-6736(96)01109-9 Petitti, 1986, Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage, Am J Med, 81, 255, 10.1016/0002-9343(86)90260-3 van der Meer, 1993, Bleeding complications in oral anticoagulant therapy, Arch Intern Med, 153, 1557, 10.1001/archinte.1993.00410130073007 Baker, 1961, An evaluation of anticoagulant therapy in the treatment of cerebrovacular disease, Neurology, 11, 132, 10.1212/WNL.11.4_Part_2.132 Bjerkelund, 1957, The effect of long-term treatment with dicumarol in myocardial infarction, Acta Med Scand, 158, 1 Bjerkelund, 1963, Therapeutic level in long-term anticoagulant therapy after myocardial infarction, Am J Cardiol, 1, 158, 10.1016/0002-9149(63)90056-0 Breddin, 1980, Secondary prevention of myocardial infarction, Haemostasis, 9, 325 Fisher, 1961, Anticoagulant therapy in cerebral thrombosis and cerebral embolism, Neurology, 11, 119, 10.1212/WNL.11.4_Part_2.119 Loeliger, 1967, A double-blind trial of long-term anticoagulant treatment after myocardial infarction, Act Med Scand, 182, 549, 10.1111/j.0954-6820.1967.tb10881.x McDowell, 1963, Anticoagulant therapy, Arch Neurol, 8, 209, 10.1001/archneur.1963.00460020109009 Meuwissen, 1969, Double blind trial of long-term anticoagulant treatment after myocardial infarction, Acta Med Scand, 186, 361, 10.1111/j.0954-6820.1969.tb01488.x Nelson, 1982, Risk of complications during intravenous heparin therapy, West J Med, 136, 189 1980, A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction, Lancet, 2, 989 Laupacis, 1994, User’s guides to the medical literature, JAMA, 272, 234, 10.1001/jama.1994.03520030076032 Gurwitz, 1992, Aging and the anticoagulant response to warfarin therapy, Ann Intern Med, 116, 901, 10.7326/0003-4819-116-11-901 Landefeld, 1989, Bleeding in outpatients treated with warfarin, Am J Med, 87, 153, 10.1016/S0002-9343(89)80690-4